Paclitaxel versus doxorubicin as first-line single-agent chemotherapy for metastatic breast cancer: a European Organization for Research and Treatment of Cancer Randomized Study with cross-over (Q73445633)
Jump to navigation
Jump to search
scientific article published on 01 February 2000
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Paclitaxel versus doxorubicin as first-line single-agent chemotherapy for metastatic breast cancer: a European Organization for Research and Treatment of Cancer Randomized Study with cross-over |
scientific article published on 01 February 2000 |
Statements
Paclitaxel versus doxorubicin as first-line single-agent chemotherapy for metastatic breast cancer: a European Organization for Research and Treatment of Cancer Randomized Study with cross-over (English)
R Paridaens
P Bruning
J G Klijn
T Gamucci
S Houston
R Coleman
J Schachter
A Van Vreckem
R Sylvester
A Awada
J Wildiers
1 February 2000